Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
34.11
+1.15 (3.49%)
At close: Aug 19, 2026, 4:00 PM EDT
33.93
-0.18 (-0.53%)
Pre-market: Aug 20, 2026, 4:45 AM EDT

Genmab Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
1,1558961,0581,0229257151,027828.58779603705.75668.34611.08413.3738.08538.51444.82316.23400.59359.93
Revenue Growth (YoY)
24.87%25.31%3.03%23.34%18.74%18.57%45.50%23.98%27.48%45.90%-4.38%24.11%37.38%30.70%84.25%49.61%41.47%26.76%19.25%32.35%
Cost of Revenue
84658158574253.0440.83282718.6911.213.08-------
Gross Profit
1,071831977964868673973.83787.75751576687.06657.13608.01413.3738.08538.51444.82316.23400.59359.93
Selling, General & Admin
205166208148144126196.25129.37129125138.51121.98121.2298.59132.3388.2889.0567.4578.3147.68
Research & Development
459440526357364359430.58341.45361335288.88296.16271.61253.9230.32195.8180.35172.07198.54173.58
Operating Expenses
664606734505508485626.84470.82490460427.39418.14392.83352.49362.64284.08269.4239.52276.85221.26
Operating Income
407225243459360188346.99316.92261116259.67239215.1860.81375.43254.43175.4276.71123.74138.68
Interest Expense
-110-112-44-3-9-5-8.84-2.69-3-4-3.11-1.28-3.66-0.88-0.72-0.79-0.84-0.6-0.46-0.62
Interest & Investment Income
36144832253336.9724.23424645.9734.6133.272820.1112.787.175.375.355.45
Currency Exchange Gain (Loss)
-6-8-10-1061183.81-100.21246-172.62101.27-1.47-62.56-318.1191.84195.6859.8464.3974.17
EBT Excluding Unusual Items
327119237478382227458.93238.25302204129.91373.6243.3225.3876.72458.26377.44141.32193.03217.67
Merger & Restructuring Charges
-32-45-185----5.66-2.54-25-----------
Gain (Loss) on Sale of Investments
--344117100.621.39304519.435.114.9813.4210.92-27.14-27.29-49.99-45.28-35.21
Asset Writedown
---------------5.46-----
Pretax Income
2957455482423244553.87257.1307249149.34378.71248.338.7982.18431.12350.1591.33147.76182.46
Income Tax Expense
-82124818749-23.9867.751045745.0880.2852.628.178.3390.9184.1221.9438.2443.78
Net Income
3035331401336195577.85189.35203192104.25298.43195.6830.6373.85340.21266.0269.39109.52138.68
Net Income to Common
3035331401336195577.85189.35203192104.25298.43195.6830.6373.85340.21266.0269.39109.52138.68
Net Income Growth (YoY)
-9.82%-72.82%-94.64%111.78%65.52%1.56%454.28%-36.55%3.74%526.93%41.17%-12.28%-26.44%-55.87%-32.57%145.32%445.21%-59.88%14.70%65.87%
Shares Outstanding (Basic)
6163626262646463646565656565656566656565
Shares Outstanding (Diluted)
6264636262646464656566666666666666666666
Shares Change (YoY)
-0.46%-0.12%-1.76%-2.87%-4.42%-2.10%-2.74%-2.99%-1.48%-0.80%-0.01%-0.07%-0.23%-0.19%-0.11%-0.24%0.05%-0.04%0.09%0.23%
EPS (Basic)
4.940.840.506.515.443.069.102.983.152.961.604.573.000.471.135.214.061.061.672.12
EPS (Diluted)
4.910.830.506.465.423.059.002.963.132.941.584.532.970.471.125.164.031.051.662.10
EPS Growth (YoY)
-9.41%-72.79%-94.44%118.03%73.16%3.74%470.59%-34.60%5.29%531.96%41.20%-12.22%-26.27%-55.78%-32.50%145.90%444.94%-59.86%14.62%65.49%

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
49-228853452275409.61298.38215215238.02275.0249.69456.6141.38248.5125.3479.0926.4657.65
Free Cash Flow Per Share
0.79-0.034.568.600.844.306.384.673.313.293.604.170.766.940.633.771.901.200.400.87
Gross Margin
92.73%92.75%92.34%94.33%93.84%94.13%94.83%95.07%96.41%95.52%97.35%98.32%99.50%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
35.24%25.11%22.97%44.91%38.92%26.29%33.79%38.25%33.50%19.24%36.79%35.76%35.21%14.71%50.87%47.25%39.44%24.26%30.89%38.53%
Profit Margin
26.23%5.92%2.93%39.24%36.32%27.27%56.27%22.85%26.06%31.84%14.77%44.65%32.02%7.41%10.01%63.18%59.80%21.94%27.34%38.53%
Free Cash Flow Margin
4.24%-0.22%27.22%52.25%5.62%38.46%39.89%36.01%27.60%35.66%33.73%41.15%8.13%110.48%5.61%46.15%28.18%25.01%6.61%16.02%
EBITDA
423244253471376204353.03329.64271126265.16247.93223.0968.69383.19262.6184.1585.96133.23147.64
EBITDA Margin
36.62%27.23%23.91%46.09%40.65%28.53%34.38%39.78%34.79%20.89%37.57%37.10%36.51%16.62%51.92%48.76%41.40%27.18%33.26%41.02%
D&A For EBITDA
1619101216166.0412.7110105.498.947.927.887.768.178.729.259.488.96
EBIT
407225243459360188346.99316.92261116259.67239215.1860.81375.43254.43175.4276.71123.74138.68
EBIT Margin
35.24%25.11%22.97%44.91%38.92%26.29%33.79%38.25%33.50%19.24%36.79%35.76%35.21%14.71%50.87%47.25%39.44%24.26%30.89%38.53%
Effective Tax Rate
-28.38%43.64%16.80%20.57%20.08%-26.35%33.88%22.89%30.19%21.20%21.19%21.05%10.14%21.09%24.03%24.02%25.88%24.00%
SEC Filings: 10-K · 10-Q